Akers Biosciences (Akers Biosciences) 3-Year Dividend Growth Rate : 0.00% (As of Dec. 2020)

View and export this data going back to 2014. Start your Free Trial

What is Akers Biosciences 3-Year Dividend Growth Rate?

Akers Biosciences's Dividends per Share for the three months ended in Dec. 2020 was $0.00.

The historical rank and industry rank for Akers Biosciences's 3-Year Dividend Growth Rate or its related term are showing as below:

AKER's 3-Year Dividend Growth Rate is not ranked ^*
in the Medical Devices & Instruments industry.
Industry Median: 11.9
* Ranked among companies with meaningful 3-Year Dividend Growth Rate only.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average dividends per share growth rate.

Akers Biosciences's Dividend Payout Ratio for the three months ended in Dec. 2020 was 0.00. As of today, Akers Biosciences's Dividend Yield % is 0.00%.

For more information regarding to dividend, please check our Dividend Page.

Competitive Comparison of Akers Biosciences's 3-Year Dividend Growth Rate

For the Medical Instruments & Supplies subindustry, Akers Biosciences's 3-Year Dividend Growth Rate, along with its competitors' market caps and 3-Year Dividend Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Akers Biosciences's 3-Year Dividend Growth Rate Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Akers Biosciences's 3-Year Dividend Growth Rate distribution charts can be found below:

* The bar in red indicates where Akers Biosciences's 3-Year Dividend Growth Rate falls into.

Akers Biosciences 3-Year Dividend Growth Rate Calculation

This is the average annual rate that a company has been raising its dividends. The growth rate is calculated with expontential compound based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average dividends per share growth rate.

Akers Biosciences (NAS:AKER) 3-Year Dividend Growth Rate Explanation

1. Dividend Payout Ratio measures the percentage of the company's earnings paid out as dividends.

Akers Biosciences's Dividend Payout Ratio for the quarter that ended in Dec. 2020 is calculated as

Dividend Payout Ratio	=	Dividends per Share (Q: Dec. 2020 )	/	EPS without NRI (Q: Dec. 2020 )
	=	0	/	-0.353
	=	N/A

2. Dividend Yield % measures how much a company pays out in dividends each year relative to its share price.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Akers Biosciences 3-Year Dividend Growth Rate Related Terms>

Akers Biosciences (Akers Biosciences) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Akers Biosciences Inc (NAS:AKER) » Definitions » 3-Year Dividend Growth Rate

Comparable Companies

Traded in Other Exchanges

N/A

Address

1185 Avenue of the Americas, 3rd Floor, New York, NY, USA, 10036

Website

http://www.akersbio.com

Akers Biosciences Inc is engaged in developing, manufacturing and supplying rapid, point-of-care screening and testing products designed to bring health-related information directly to the patient or clinician in a time- and cost-efficient manner. The pipeline products of the company focus on delivering diagnostic assistance in a variety of healthcare fields/specialties, including cardiology/emergency medicine, metabolism/nutrition, diabetes, respiratory diseases and infectious disease detection. The majority of the company's revenue comes from the United States.

Executives

Billy Joe White	director	191 OTTO ST., PORT TOWNSEND WA 98368
Joshua Silverman	director	IROQUOIS CAPITAL MANAGEMENT LLC, 205 EAST 42ND ST - 20TH FL., NEW YORK NY 10017
Christopher C Schreiber	director, officer: Exec. Chairman and President	AKERS BIOSCIENCES, INC., 201 GROVE ROAD, THOROFARE NJ 08086
Robert C Schroeder	director	37 MAIN STREET, COLD SPRING HARBOR, NEW YORK NY 11724
Stuart M Benson	officer: Chief Financial Officer	EMPIRE STATE BUILDING, 350 5TH AVE., SUITE 7520, NEW YORK NY 10118
Hudson Bay Capital Management Lp	10 percent owner	28 HAVEMEYER PLACE, 2ND FLOOR, GREENWICH CT 06830
Sander Gerber	10 percent owner	C/O HUDSON BAY CAPITAL MANAGEMENT, L.P., 28 HAVEMEYER PLACE, 2ND FLOOR, GREENWICH CT 06830
Howard Yeaton	officer: CEO, CFO	79 LLOYD ROAD, HOHOKUS NJ 07423
John J Gormally	director, officer: Chief Executive Officer	80 WALSH DRIVE, MAHWAH NJ 07430
Gary M Rauch	officer: VP - Finance, Treasurer	842 ST REGIS COURT, WEST DEPTFORD NJ 08051
Tarbox Richard C Iii	director	AKERS BIOSCIENCES, INC., 201 GROVE ROAD, THOROFARE NJ 08086
Brandon Thomas Knox	director	771 EAGLE ROAD, VILLANOVA PA 19085
Akers Raymond Francis Jr	director, officer: Executive Chairman, Secretary	171 E. ESSEX AVE, SEWELL NJ 08080
Thomas J Knox	director	1717 ARCH STREET, SUITE 3820, PHILADELPHIA PA 19103
Robert E Andrews	director	215 4TH AVENUE, HADDON HEIGHTS NJ 08035